(Q28184952)

title

Trospium chloride: a quaternary amine with unique pharmacologic properties (English)

0 references

Trospium chloride: A quaternary amine with unique pharmacologic properties (English)

1 reference

https://api.crossref.org/works/10.1007/S11934-003-0023-1

2 April 2024

1 reference

1 reference

https://api.crossref.org/works/10.1007/S11934-003-0023-1

2 April 2024

author name string

Raymond W. Pak

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14622495

2 April 2024

Steven P. Petrou

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14622495

2 April 2024

David R. Staskin

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14622495

full work available at URL

2 April 2024

language of work or name

English

0 references

publication date

December 2003

0 references

http://link.springer.com/content/pdf/10.1007/s11934-003-0023-1.pdf

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1007/S11934-003-0023-1

http://link.springer.com/article/10.1007/s11934-003-0023-1/fulltext.html

2 April 2024

1 reference

https://api.crossref.org/works/10.1007/S11934-003-0023-1

http://link.springer.com/content/pdf/10.1007/s11934-003-0023-1

2 April 2024

1 reference

https://api.crossref.org/works/10.1007/S11934-003-0023-1

Muscarinic antagonists in development for disorders of smooth muscle function

2 April 2024

published in

Current urology reports

0 references

volume

4

0 references

issue

6

0 references

page(s)

436-40

0 references

cites work

1 reference

12 December 2020

Selective muscarinic receptor agonists and antagonists

1 reference

12 December 2020

Current and future pharmacological treatment for overactive bladder

1 reference

12 December 2020

Importance of pharmacological and physicochemical properties for tolerance of antimuscarinic drugs in the treatment of detrusor instability and detrusor hyperreflexia--chances for improvement of therapy

1 reference

12 December 2020

Trospium chloride--an effective drug in the treatment of overactive bladder and detrusor hyperreflexia

1 reference

12 December 2020

Studies on pharmacokinetics and biotransformation of ipratropiumbromide in man (author's transl)

1 reference

12 December 2020

Effects of tolterodine, trospium chloride, and oxybutynin on the central nervous system

1 reference

12 December 2020

Influences of trospium chloride and oxybutynin on quantitative EEG in healthy volunteers.

1 reference

12 December 2020

Application of a radioreceptor assay in a pharmacokinetic study of oxitropium bromide in healthy volunteers after single i.v., oral and inhalation doses

1 reference

12 December 2020

Pharmacology of incontinence.

1 reference

12 December 2020

Trospium chloride: an effective option for medical treatment of bladder overactivity.

1 reference

12 December 2020

M(3) receptor antagonism by the novel antimuscarinic agent solifenacin in the urinary bladder and salivary gland

1 reference

12 December 2020

The gastrointestinal absorption and the excretion of H3-butylscopolamine (hyoscine butylbromide) in man

1 reference

12 December 2020

Discussion: functional role of M(1), M(2), and M(3) muscarinic receptors in overactive bladder

1 reference

12 December 2020

[Intravesical instillation of trospium chloride, oxybutynin and verapamil for relaxation of the bladder detrusor muscle. A placebo controlled, randomized clinical test]

1 reference

12 December 2020

Advancements in pharmacologic management of the overactive bladder

1 reference

12 December 2020

Trospium chloride versus oxybutynin: a randomized, double-blind, multicentre trial in the treatment of detrusor hyper-reflexia

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of tolterodine in man: a new drug for the treatment of urinary bladder overactivity

1 reference

12 December 2020

Controlled, double-blind, multicentre clinical trial to investigate long-term tolerability and efficacy of trospium chloride in patients with detrusor instability

1 reference

12 December 2020

Intravesical application of oxybutynine: mode of action in controlling detrusor hyperreflexia. Preliminary results

1 reference

12 December 2020

Inhibitory effects of trospium chloride on cytochrome P450 enzymes in human liver microsomes

1 reference

12 December 2020

Effect of the quaternary ammonium compound trospium chloride on 24 hour jejunal motility in healthy subjects

1 reference

12 December 2020

Bioavailability of trospium chloride after intravesical instillation in patients with neurogenic lower urinary tract dysfunction: A pilot study

1 reference

12 December 2020

Determination of the bioavailability of the quaternary compound trospium chloride in man from urinary excretion data

1 reference

12 December 2020

39

50

217

KW Herberg

1999

1 reference

https://api.crossref.org/works/10.1007/S11934-003-0023-1

2 April 2024

Identifiers

Dimensions Publication ID

0 references

1011406542

0 references